0002067625-25-000001.txt : 20250523 0002067625-25-000001.hdr.sgml : 20250523 20250523115732 ACCESSION NUMBER: 0002067625-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250523 DATE AS OF CHANGE: 20250523 EFFECTIVENESS DATE: 20250523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Branch Therapeutics, Inc. CENTRAL INDEX KEY: 0002067625 ORGANIZATION NAME: EIN: 331241756 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-547059 FILM NUMBER: 25980143 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: TMCI PARTNERS OFFICE 1.319 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 615-351-1950 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: TMCI PARTNERS OFFICE 1.319 CITY: HOUSTON STATE: TX ZIP: 77021 D 1 primary_doc.xml X0708 D LIVE 0002067625 Branch Therapeutics, Inc. 2450 HOLCOMBE BLVD TMCI PARTNERS OFFICE 1.319 HOUSTON TX TEXAS 77021 615-351-1950 DELAWARE None None Corporation true 2024 Curtis Thorne 3327 N Christmas Ave Tucson AZ ARIZONA 85716 Executive Officer Director CEO and Director Christopher Hulme 12063 N Red Mountain Dr Oro Valley AZ ARIZONA 85755 Director Sourav Banerjee 64 Alastair Soutar Crescent Invergowrie Dundee X0 UNITED KINGDOM DD2 5BN Director Pharmaceuticals Decline to Disclose 06b false 2025-04-30 false true false 0 3999994 3999994 0 false 1 0 0 0 false Branch Therapeutics, Inc. Curtis Thorne Curtis Thorne CEO 2025-05-22